Using several techniques to knockdown and overexpress the CAV1 gene in human and mouse hepatocytes, we observed markedly aggravated and attenuated lipid accumulation, respectively, in the FFA-induced NAFLD in vitro models. The gene discussed is CAV1; the disease is metabolic dysfunction-associated steatotic liver disease.